Issue Archive
November 2026 | Volume 25 | Issue 11
Editorials
Biomarkers and Clinical Disease Severity in Hidradenitis Suppurativa: A Linear Mixed-Effects Modeling Study
Hidradenitis Suppurativa Increases Risk of Postoperative Complications After Mohs Surgery: A Retrospective Cohort Study
The Current Landscape of Vitiligo Support Groups: An International Survey of Support Group Leaders
Celecoxib, Sirolimus, and Acitretin are Associated With Decreased Non-Melanoma Skin Cancer in the General Population
Original Articles
Practical Algorithm Guiding Seborrheic Dermatitis Treatment in Adults and Adolescents: New Evidence and Consensus Expert Opinion
Background: Seborrheic dermatitis (SD) is a common, chronic inflammatory skin disease characterized by greasy, scaly plaques on the scalp or body, often with pruritus and impaired quality of life. The...
Read MoreA Moisturizer With Centella asiatica and Mandelic Acid Reduces Bruising and Speeds Recovery in Mature Skin
Background: Dermatoporosis is a chronic cutaneous insufficiency syndrome characterized by skin atrophy, purpura, bruising, delayed healing, and increased injury susceptibility. This study evaluated an...
Read MoreEvaluating the Clinical Efficacy, Utility, and Role of the 40-Gene Expression Profiling Test in Assessing Prognosis of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel
Background: The 40-gene expression profiling (40-GEP) test has been validated to identify patients at highest risk for nodal or distant metastasis, as well as those most likely to benefit from adjuvan...
Read MoreImplementing Psoriatic Arthritis Screening and Dietary Interventions in Dermatology Practice: A Prospective Clinical Study
Background: Psoriatic arthritis (PsA) is a common, underdiagnosed inflammatory comorbidity of psoriasis (PsO) that can lead to irreversible joint damage without early intervention. Dermatologists are ...
Read MorePeptides for Hair Growth and Treatment of Hair Loss and Alopecia: A Systematic Review
Background: Patients desire products that will result in hair growth and treatments to address concerns of hair loss in alopecia. Peptide-based formulations represent established, promising, and safe ...
Read MoreImmunosuppressive and Immunomodulatory Dermatologic Therapies: Cancer Risk for Patients With Active or Prior Malignancy
Background: The use of immunosuppressive and immunomodulatory medications in dermatology remains challenging in patients with active or prior malignancy due to concerns of cancer risk. Clinical trials...
Read MoreIncreased Risk of Skin Cancers in Certain Occupations
Ultraviolet radiation (UVR) is the main risk factor for the development of skin cancer, and outdoor workers are especially at risk. Despite this, there is a lack of educational programs, and preventat...
Read MoreTranexamic Acid Mesotherapy for Melasma: An Interventional Study
Background: Tranexamic acid (TXA), an anti-fibrinolytic agent traditionally used to manage blood loss, has shown promising results in the treatment of melasma. Studies on the efficacy of intradermal T...
Read MoreBruton Tyrosine Kinase Inhibitors for Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials
Background: Systemic lupus erythematosus (SLE) is a chronic relapsing autoimmune disease with frequent cutaneous involvement and unmet treatment need. Given safety and efficacy concerns with first-lin...
Read MoreGenerative Artificial Intelligence Augmentation of a Clinical Trial of a Dermo-cosmetic Intervention for Acne Remission Maintenance
Background: A practical application of artificial intelligence (AI) in healthcare is to generate artificial datasets that capture the characteristics of a real source dataset without exposing protecte...
Read MoreImpetigo Antibiotic Stewardship and the Need for Treatment Alternatives
Background: Impetigo is a highly contagious bacterial skin infection, primarily caused by Staphylococcus aureus and, less frequently, Streptococcus pyogenes. Although typically self-limiting, treatmen...
Read MoreProgression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors
Background: Psoriasis is a chronic immune-mediated inflammatory disease that may progress to psoriatic arthritis (PsA). Although multiple systemic therapies are available, including interleukin (IL)-1...
Read More
Features
Case Reports
Central Centrifugal Cicatricial Alopecia and the Use of Xtressé Nutrient Supplement: A Case Series
Central Centrifugal Cicatricial Alopecia (CCCA) is a form of scarring alopecia characterized by patches of permanent hair loss that manifests on the crown of the scalp, progressively spreading outward...
Read MoreQ-switched Nd:YAG Laser for Extrafacial Lichen Planus Pigmentosus: A Case Series Highlighting Outcomes and Risks
Lichen planus pigmentosus (LPP) is a challenging pigmentary disorder that often affects extrafacial sites, yet most published data on laser treatment focus on facial involvement. We report 3 cases of ...
Read More
Departments
FULL SUPPLEMENT: Emerging Technologies to Manage Grey Hair
Greying of hair, also called canities or achromotrichia, is part of the natural aging process. It has been reported that worldwide, 74% of men and women between the ages of 45 and 65 have some grey ha...
Read MoreFULL SUPPLEMENT: The Hidden Burden of Topical Corticosteroids: Integrating Literature, Prescribing Information, and Real-World Evidence
Supplements
INDIVIDUAL ARTICLE: Randomized Double-Blind, Placebo-Controlled Study of a Supplement and Serum on Grey Hair
Worldwide, 74% of men and women between the ages of 45 and 65 have some grey hair. Currently, there is no treatment that has been shown in a clinical trial to repigment or slow the development of grey...
Read MoreINDIVIDUAL ARTICLE: Real-World Study of Topical Corticosteroid-Associated Adverse Events in the FDA Adverse Event Reporting System
Background: Corticosteroids (CS) and topical CS (TCS) are widely used, yet the real-world burden and reporting patterns of associated adverse events (AEs) remain incompletely characterized.
Meth...
Read MoreINDIVIDUAL ARTICLE: Cutaneous and Systemic Adverse Events Associated With Topical Corticosteroid Use: A Targeted Literature Review
Background: Topical corticosteroids (TCS) have been used to treat chronic inflammatory skin conditions since initial approval in 1950, which was followed by reports of cutaneous and systemic adverse e...
Read MoreINDIVIDUAL ARTICLE: Topical Corticosteroid Approved Labeling in the US: A Modern Inter- and Intra-Product Analysis
Background: A wide variety of prescription-strength topical corticosteroids (TCS) have been commercially available for many decades. Product labels often vary, reflecting inconsistent guidance for dos...
Read More
